Figure 5From: Analysis of machine perfusion benefits in kidney grafts: a preclinical studyEMT development. A, B, C and D: Representative staining for Vimentin at 3 months. E: quantification of staining in each group. Shown are mean Ā± SEM, statistics: ā : p < 0.05 to ViaspanUW CS; * : p < 0.05 to ViaspanUW MP; Ā° : p < 0.05 to KPS CS; Ā¶ : p < 0.05 to KPS-MP.Back to article page